CardioTech to start MyoLink vascular graft trial:
This article was originally published in Clinica
CardioTech International, of Woburn, Massachusetts, is to begin a European trial of its MyoLink small diameter vascular graft. The study, at the Royal Free Hospital in London, UK, will recruit 20 patients who require lower limb bypass and is aimed at below-knee bypass where current synthetic grafts are unsatisfactory. The studies will be used to support CE marking.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.